ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

IMUX Immunic Inc

1,14
-0,05 (-4,20%)
17 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Immunic Inc IMUX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,05 -4,20% 1,14 17:30:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,19 1,12 1,20 1,14 1,19
mais cotações »

Notícias Recentes

Data Hora Fonte Título
28/05/202407:30PRNUSImmunic to Participate in Industry and Scientific..
08/05/202407:30PRNUSImmunic, Inc. Reports First Quarter 2024 Financial Results..
06/05/202407:30PRNUSImmunic to Participate in Investor and Scientific..
01/05/202407:30PRNUSImmunic, Inc. to Announce Financial Results for the First..
30/04/202407:30PRNUSImmunic Announces Publication of Extended Data From Phase 2..
04/04/202407:30PRNUSImmunic to Host MS R&D Day and Participate in Investor..
20/03/202407:30PRNUSImmunic Receives Notice of Allowance for..
07/03/202408:30PRNUSImmunic to Participate in Investor and Scientific..
29/02/202408:30PRNUSImmunic Presents Data From Phase 2 CALLIPER and CALVID-1..
22/02/202408:30PRNUSImmunic, Inc. Reports Year End 2023 Financial Results and..
15/02/202408:30PRNUSImmunic, Inc. to Announce Financial Results for the Year..
01/02/202408:30PRNUSImmunic to Participate in Investor and Scientific..
05/01/202408:35PRNUSImmunic Highlights 2023 Accomplishments and Upcoming..
05/01/202408:30PRNUSImmunic, Inc. Announces Private Placement of up to $240..
21/11/202308:30PRNUSImmunic Receives Notice of Allowance for United States..
14/11/202308:30PRNUSImmunic, Inc. Reports Third Quarter 2023 Financial Results..
07/11/202308:30PRNUSImmunic to Announce Financial Results for the Third Quarter..
02/11/202307:30PRNUSImmunic Receives Notice of Allowance for United States..
26/10/202307:30PRNUSImmunic to Participate in Scientific and Industry..
16/10/202307:30PRNUSImmunic Presents Data From Phase 2 CALDOSE-1 Trial of..
15/10/202307:30PRNUSImmunic Presents Data From Phase 1b Clinical Trial of..
11/10/202307:30PRNUSImmunic Presents Data From Phase 2 EMPhASIS Trial of..
09/10/202317:01PRNUSImmunic Reports Positive Interim Data from Phase 2 CALLIPER..
04/10/202307:30PRNUSImmunic to Participate in Scientific Conferences in October
06/09/202307:30PRNUSImmunic to Participate in Industry and Investor Conferences..
17/08/202307:30PRNUSImmunic Completes Enrollment of Its Phase 2 CALLIPER Trial..
03/08/202307:30PRNUSImmunic, Inc. Reports Second Quarter 2023 Financial Results..
01/08/202307:30PRNUSImmunic to Participate in Investor and Scientific..
27/07/202307:30PRNUSImmunic, Inc. to Announce Financial Results for the Second..
29/06/202307:30PRNUSImmunic to Participate in Scientific and Investor..

Seu Histórico Recente

Delayed Upgrade Clock